BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 15239937)

  • 1. Proteomic profiling of cancer biomarkers.
    Shau H; Chandler GS; Whitelegge JP; Gornbein JA; Faull KF; Chang HR
    Brief Funct Genomic Proteomic; 2003 Jul; 2(2):147-58. PubMed ID: 15239937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MALDI mass spectrometry in prostate cancer biomarker discovery.
    Flatley B; Malone P; Cramer R
    Biochim Biophys Acta; 2014 May; 1844(5):940-9. PubMed ID: 23831156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic patterns of tumour subsets in non-small-cell lung cancer.
    Yanagisawa K; Shyr Y; Xu BJ; Massion PP; Larsen PH; White BC; Roberts JR; Edgerton M; Gonzalez A; Nadaf S; Moore JH; Caprioli RM; Carbone DP
    Lancet; 2003 Aug; 362(9382):433-9. PubMed ID: 12927430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SELDI-TOF-MS proteomics of breast cancer.
    Clarke CH; Buckley JA; Fung ET
    Clin Chem Lab Med; 2005; 43(12):1314-20. PubMed ID: 16309366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic strategies for the characterization and the early detection of lung cancer.
    Massion PP; Caprioli RM
    J Thorac Oncol; 2006 Nov; 1(9):1027-39. PubMed ID: 17409991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An introduction into proteomics and its clinical applications.
    Ahram M
    Saudi Med J; 2007 Apr; 28(4):499-507. PubMed ID: 17457467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate cancer proteomics: Current trends and future perspectives for biomarker discovery.
    Tanase CP; Codrici E; Popescu ID; Mihai S; Enciu AM; Necula LG; Preda A; Ismail G; Albulescu R
    Oncotarget; 2017 Mar; 8(11):18497-18512. PubMed ID: 28061466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomics in the search for biomarkers of animal cancer.
    Kycko A; Reichert M
    Curr Protein Pept Sci; 2014 Feb; 15(1):36-44. PubMed ID: 24555898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic technology for biomarker profiling in cancer: an update.
    Alaoui-Jamali MA; Xu YJ
    J Zhejiang Univ Sci B; 2006 Jun; 7(6):411-20. PubMed ID: 16625706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteome analysis for the identification of tumor-associated biomarkers in gastrointestinal cancer.
    Fels LM; Buschmann T; Meuer J; Reymond MA; Lamer S; Röcken C; Ebert MP
    Dig Dis; 2003; 21(4):292-8. PubMed ID: 14752218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innovative proteomic approaches for cancer biomarker discovery.
    Faca V; Krasnoselsky A; Hanash S
    Biotechniques; 2007 Sep; 43(3):279, 281-3, 285. PubMed ID: 17907570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Identification of differentially expressed proteins and its applications of isolated proteins].
    Lai MD; Wang YH
    Zhonghua Bing Li Xue Za Zhi; 2007 Feb; 36(2):76-8. PubMed ID: 17493378
    [No Abstract]   [Full Text] [Related]  

  • 13. SELDI proteinchip MS: a platform for biomarker discovery and cancer diagnosis.
    Wright GL
    Expert Rev Mol Diagn; 2002 Nov; 2(6):549-63. PubMed ID: 12465452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic analysis of gliomas.
    Whittle IR; Short DM; Deighton RF; Kerr LE; Smith C; McCulloch J
    Br J Neurosurg; 2007 Dec; 21(6):576-82. PubMed ID: 18071984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive modeling in proteomics-based disease detection.
    Pham TD
    Annu Int Conf IEEE Eng Med Biol Soc; 2007; 2007():3308-11. PubMed ID: 18002703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncoproteomics: Trials and tribulations.
    Zhou L; Li Q; Wang J; Huang C; Nice EC
    Proteomics Clin Appl; 2016 Apr; 10(4):516-31. PubMed ID: 26518147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer proteomics: a review for clinicians.
    Galvão ER; Martins LM; Ibiapina JO; Andrade HM; Monte SJ
    J Cancer Res Clin Oncol; 2011 Jun; 137(6):915-25. PubMed ID: 21465318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of β-tubulin as a common immunogen in gastrointestinal malignancy by mass spectrometry of colorectal cancer proteome: implications for early disease detection.
    Bouras G; Nakanishi T; Fujita Y; Tsunemi S; Takubo T; Tanigawa N
    Anal Bioanal Chem; 2012 Jun; 403(7):1801-9. PubMed ID: 22271099
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasma proteomic pattern as biomarkers for ovarian cancer.
    Lin YW; Lin CY; Lai HC; Chiou JY; Chang CC; Yu MH; Chu TY
    Int J Gynecol Cancer; 2006; 16 Suppl 1():139-46. PubMed ID: 16515582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in clinical cancer proteomics: SELDI-ToF-mass spectrometry and biomarker discovery.
    Seibert V; Ebert MP; Buschmann T
    Brief Funct Genomic Proteomic; 2005 May; 4(1):16-26. PubMed ID: 15975261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.